Lobe Sciences Ltd. (LOBE.CN) AI-Powered Stock Analysis
See how Lobe Sciences Ltd. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
LOBE.CN●CNQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.08
$0.00(0.00%)
Canadian Market is Open · 09:32
Advertisement
Lobe Sciences Ltd. (LOBE.CN)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerLobe Sciences Ltd. (LOBE.CN) Stock Overall Grade
Lobe Sciences Ltd.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Lobe Sciences Ltd.'s overall stock rating.
Forecast
C+Score
55/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
59/100Key Ratios
BScore
63/100Sector Comparison
C+Score
50/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
50/100Lobe Sciences Ltd. (LOBE.CN) AI-Powered Stock Analysis
This asset demonstrates Normal performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (59/100, C+) highlight its stability, while Key Ratios (63/100, B) and Sector Comparison (50/100, C+) indicate weak positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests Low divergence in outlook.Component Analysis Explained
Understand the key factors behind each Lobe Sciences Ltd. stock grade, including financials, comparisons, and forecasts.